Innovex Announces Second Quarter 2026 Results

Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the second quarter of 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260803958068/en/

Innovex delivered an excellent second quarter – with revenue at the high end of the guidance range and strong operational execution across the business.

Innovex delivered an excellent second quarter – with revenue at the high end of the guidance range and strong operational execution across the business.

Second Quarter Highlights

  • Revenue of $245 million, up 2% quarter-over-quarter and up 9% year-over-year

  • Net Income of $25 million and Net Income Margin of 10%

  • Adjusted EBITDA1 of $48 million and Adjusted EBITDA Margin1 of 20%

  • Net Cash Provided by Operating Activities of $37 million

  • Free Cash Flow1 of $30 million

  • Income from Operations of $100 million (twelve months ended June 30, 2026)

  • Return on Capital Employed1 of 12% (twelve months ended June 30, 2026)

  • $222 million of cash and cash equivalents and no bank debt at quarter-end

  • Awarded an additional $20 million subsea tension riser package for an operator in Malaysia, with follow-on wellhead awards anticipated

  • Completed the first successful XPak trial with a major independent oil company in Asia

  • Closed the acquisition of TCO Group AS (“TCO”) in a cash and stock transaction valued at $95 million on July 1, 2026

(1)

Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and Return on Capital Employed (“ROCE”) are non-GAAP measures. Reconciliations of Adjusted EBITDA to net income, Free Cash Flow to net cash provided by operating activities, and ROCE to income from operations, the most directly comparable financial measures presented in accordance with GAAP, are outlined in the reconciliation tables accompanying this release.

Adam Anderson, CEO, commented, “We delivered an excellent second quarter – with revenue at the high end of our guidance range and strong operational execution across the business. Performance was supported by improving activity in key international markets and growing commercial momentum within our subsea business. Our ‘No Barriers’ culture has unleashed our subsea teams – as evidenced by a $20 million subsea award in Malaysia, the first successful XPak trial for a major operator in Asia Pacific, and the first installation of our ArgoLATCH Subsea Release Plug in a key deepwater exploration well in Brazil – an innovation that combines technologies from both legacy Innovex and legacy Dril-Quip. Improving end-market fundamentals, innovation, and strong execution are expected to continue supporting momentum in our subsea business results over the coming quarters. Our Canadian wellhead team also completed its first surface wellhead delivery to Mexico during the quarter, leveraging Innovex’s international platform to expand into a new market. These results reflect the strength of our differentiated technology portfolio and the benefits of our customer-focused culture. On July 1st, we completed the acquisition of TCO, a highly complementary, capital-light business that expands our technology offering, strengthens our international presence, and exemplifies our disciplined ‘big impact, small ticket’ acquisition strategy.”

Kendal Reed, CFO, continued, “Our second quarter results demonstrate the strength of Innovex’s capital-light business model. We generated $30 million of Free Cash Flow and ended the quarter with $222 million of cash and cash equivalents and no bank debt, providing significant financial flexibility to invest in high-return capital allocation opportunities. We are very pleased with the completion of the TCO acquisition for $95 million, funded with a mix of cash and equity, which preserves our strong balance sheet and financial capacity to pursue our robust pipeline of M&A opportunities. TCO is an excellent example of our stringent quantitative and qualitative M&A framework in action. TCO is a high-margin, cash-generative business with a portfolio of largely consumable products that fit our ‘big impact, small ticket’ business proposition. In addition to acquiring TCO at an attractive valuation, we see meaningful opportunities to accelerate its organic growth by leveraging the Innovex platform. The transaction enhances Innovex’s corporate margin profile and is expected to be accretive to Innovex’s earnings per share.”

Financial Summary

 

 

Three months ended

 

(in thousands)

 

June 30,

2026

 

March 31,

2026

 

June 30,

2025

Revenue

 

$

244,896

 

 

$

239,031

 

 

$

224,234

 

Net income (loss)

 

 

25,031

 

 

 

(16,671

)

 

 

15,345

 

Net income (loss) % revenue

 

 

10

%

 

 

(7

)%

 

 

7

%

Adjusted EBITDA (1)

 

 

47,997

 

 

 

49,286

 

 

 

46,642

 

Adjusted EBITDA Margin (1)

 

 

20

%

 

 

21

%

 

 

21

%

Net cash provided by operating activities

 

 

37,028

 

 

 

19,840

 

 

 

59,210

 

Free Cash Flow (1)

 

 

30,387

 

 

 

14,013

 

 

 

51,913

 

Income (loss) from operations

 

 

33,782

 

 

 

(21,832

)

 

 

22,695

 

 

 

Twelve Months Ended

 

 

 

June 30,

2026

 

December 31,

2025

 

June 30,

2025

ROCE (1)

 

 

12

%

 

 

10

%

 

 

13

%

 

(1)

Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and Return on Capital Employed (“ROCE”) are non-GAAP financial measures. See definition of these measures and the reconciliation of GAAP to non-GAAP financial measures in the Supplemental Information tables below.

Operational & Financial Results

Kendal Reed, CFO, commented, “Operational execution remained strong throughout the second quarter as we continued to improve the efficiency and competitiveness of the business while delivering revenue at the high end of our guidance range. Our business in the Middle East improved relative to the first quarter and Mexico benefited from increased customer activity and continued demand for our differentiated completion technologies. Across our subsea businesses, we continued to build commercial momentum through new technology deployments, increased customer engagement and improved operational execution. While geopolitical uncertainty and project timing may continue to create quarter-to-quarter variability, we believe the underlying trajectory of the business remains positive as we enter the second half of 2026.”

Adam Anderson, CEO, concluded, “We are encouraged by the momentum across our platform of businesses. Activity across Latin America, particularly in Mexico, continues to improve. We are also seeing encouraging commercial progress in both the Middle East and Asia Pacific, including market share gains in expandable liner hanger technologies, growth in unconventional applications in Saudi Arabia, and the deployment of our technologies into new fields. I am particularly excited by the outlook for our subsea business, where improving offshore market fundamentals are complemented by our stronger competitive position, differentiated technologies, alliance with OneSubsea, and customer-focused commercial execution. Over the past several months, we have secured a number of meaningful project awards and expanded our presence with new customers and in new regions, providing us with growing confidence in the long-term trajectory of the business. Looking ahead, we are also excited about the opportunities created by the addition of TCO, whose differentiated technologies further strengthen our ability to deliver value for customers around the world.

More broadly, we believe Innovex is entering a new phase. We now have a stronger, more efficient operating platform, a broader portfolio of differentiated technologies, and greater opportunities to extend those technologies across customers, applications, and geographies. We remain focused on converting these advantages into sustainable, profitable growth while maintaining our discipline around execution and capital allocation.”

Balance Sheet, Debt, Cash Flow & Other

Net cash provided by operating activities was $37 million for the second quarter of 2026, while capital expenditures totaled $7 million (approximately 2.7% of revenue) for the second quarter of 2026.

Innovex generated Free Cash Flow of $30 million during the second quarter of 2026 and ended the quarter with approximately $222 million of cash and cash equivalents and no bank debt.

Innovex maintains a strong liquidity position and disciplined balance sheet to preserve flexibility and support high-return capital allocation opportunities. We continue to focus on M&A opportunities with strong quantitative and qualitative characteristics.

Return on Capital Employed (“ROCE”)

Innovex’s efficient capital allocation and capital-light business model enable the Company to generate strong returns on its invested capital. Income from operations for the twelve months ended June 30, 2026 was $100 million. Return on Capital Employed (“ROCE”) for the twelve months ended June 30, 2026 was 12%. We remain focused on capital efficiency, which we believe is a key driver of sustainable value creation for our stockholders.

Q3 2026 Guidance

Looking to the third quarter of 2026, Innovex expects to generate $260 – $270 million in total revenue and Adjusted EBITDA of $51 – $57 million. Q3 guidance includes TCO contributions.

The Company is unable to provide a reconciliation of Adjusted EBITDA guidance to the most directly comparable

GAAP measure without unreasonable effort due to the inherent difficulty in forecasting the timing and magnitude of

items that have not yet occurred.

Conference Call Details

Management will host a conference call and a webcast to discuss the financial results on August 4, 2026, at 9:00 a.m. Eastern Time / 8:00 a.m. Central Time. The call will be open to all interested parties and may include forward-looking statements. To access the call, please dial in approximately ten minutes prior to the start time.

Date / Time: August 4, 2026 – 9:00 a.m. Eastern Time / 8:00 a.m. Central Time

Webcast: https://events.q4inc.com/attendee/159948172

U.S. Toll-Free Dial-In: +1 (833) 461-5787

U.S. Local Dial-In: +1 (585) 542-9983

Meeting ID: 159948172

A replay of the webcast will be made available shortly after the call and may be accessed through the Investors section of the Company’s website.

About Innovex International, Inc.

Innovex International, Inc. (NYSE: INVX) is a Houston-based company established in 2024 following the merger of Dril-Quip, Inc. and Innovex Downhole Solutions, Inc.

Innovex’s comprehensive portfolio extends throughout the lifecycle of the well, and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering costs, and reducing the rig site service footprint for the customer.

With locations throughout North America, Latin America, Europe, the Middle East, and Asia, no matter where you need us, our team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service.

Forward-Looking Statements

Certain statements contained in this press release and oral statements made regarding the matters addressed in this release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of Innovex’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.

Forward-looking statements can be identified by the use of forward-looking terminology including “may,” “believe,” “expect,” “intend,” “anticipate,” “plan,” “should,” “estimate,” “continue,” “potential,” “will,” “hope” or other similar words and include the Company’s expectation of future performance contained herein. These statements discuss future expectations, contain projections of results of operations or of financial condition, or state other “forward-looking” information. You are cautioned not to place undue reliance on any forward-looking statements, which can be affected by assumptions used or by risks or uncertainties. Consequently, no forward-looking statements can be guaranteed. When considering these forward-looking statements, you should keep in mind the risks related to the Company’s merger and acquisition activities, including the ultimate outcome and results of integrating operations, the effects of the Company’s merger and acquisition activities (including the Company’s future financial condition, results of operations, strategy and plans), potential adverse reactions or changes to business relationships resulting from the completion of mergers and acquisitions, expected benefits from mergers and acquisitions and the ability of the Company to realize those benefits, the significant costs required to integrate operations, whether merger or acquisition-related litigation will occur and, if so, the results of any litigation, settlements and investigations, operating hazards, natural disasters, weather-related delays, casualty losses and other matters beyond our control; acts of terrorism, war or political or civil unrest in the United States or elsewhere; loss or corruption of our information or a cyberattack on our computer systems; uncertainties pertaining to the Impulse litigation; the risks related to economic conditions and other factors noted in the Company’s Annual Report on Form 10-K, any Quarterly Reports on Form 10-Q and the other documents that the Company files with the Securities and Exchange Commission. The risk factors and other factors noted therein could cause actual results to differ materially from those contained in any forward-looking statement. Innovex disclaims any duty to update and does not intend to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release, except as may be required by law.

Innovex International, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income

(Unaudited)

 

 

 

Three months ended

 

(in thousands, except share and per share amounts)

 

June 30,

2026

 

March 31,

2026

 

June 30,

2025

Revenues

 

$

244,896

 

 

$

239,031

 

 

$

224,234

 

Cost of revenues

 

 

161,248

 

 

 

154,522

 

 

 

152,515

 

Selling, general and administrative expenses

 

 

39,089

 

 

 

41,748

 

 

 

28,835

 

Gain on sale of assets, net

 

 

(9,853

)

 

 

(2,020

)

 

 

(419

)

Depreciation and amortization

 

 

16,213

 

 

 

16,222

 

 

 

14,974

 

Impairment of long-lived assets

 

 

 

 

 

 

 

 

503

 

Acquisition and integration costs

 

 

1,613

 

 

 

1,588

 

 

 

5,131

 

Provision for legal settlement

 

 

2,804

 

 

 

48,803

 

 

 

 

Income (loss) from operations

 

$

33,782

 

 

$

(21,832

)

 

$

22,695

 

Interest (income) expense, net

 

 

(653

)

 

 

(388

)

 

 

551

 

Other (income) expense, net

 

 

(972

)

 

 

150

 

 

 

(92

)

Income (loss) before income taxes

 

$

35,407

 

 

$

(21,594

)

 

$

22,236

 

Income tax expense (benefit), net

 

 

10,376

 

 

 

(4,923

)

 

 

6,891

 

Net income (loss)

 

$

25,031

 

 

$

(16,671

)

 

$

15,345

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per common share

 

 

 

 

 

 

 

 

 

Basic

 

$

0.36

 

 

$

(0.24

)

 

$

0.22

 

Diluted

 

$

0.36

 

 

$

(0.24

)

 

$

0.22

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

 

Basic

 

 

68,793,160

 

 

 

68,940,260

 

 

 

68,943,387

 

Diluted

 

 

69,523,359

 

 

 

68,940,260

 

 

 

69,147,457

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

25,031

 

 

$

(16,671

)

 

$

15,345

 

Foreign currency translation adjustment

 

 

(440

)

 

 

1,750

 

 

 

6,728

 

Comprehensive income (loss)

 

$

24,591

 

 

$

(14,921

)

 

$

22,073

 

Innovex International, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

(in thousands, except share and par value amounts)

 

June 30,

2026

 

March 31,

2026

 

June 30,

2025

ASSETS

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

222,055

 

 

$

200,707

 

 

$

68,781

 

Trade receivables, net

 

 

240,094

 

 

 

245,633

 

 

 

220,966

 

Inventories, net

 

 

264,837

 

 

 

252,987

 

 

 

278,495

 

Other current assets

 

 

61,541

 

 

 

53,564

 

 

 

101,863

 

Total current assets

 

 

788,527

 

 

 

752,891

 

 

 

670,105

 

Noncurrent assets

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

169,636

 

 

 

163,328

 

 

 

150,670

 

Goodwill and net intangibles

 

 

221,331

 

 

 

211,738

 

 

 

218,864

 

Right of use leases – operating, net

 

 

48,728

 

 

 

51,213

 

 

 

56,512

 

Deferred tax asset, net

 

 

89,341

 

 

 

98,226

 

 

 

122,129

 

Other long-term assets

 

 

10,184

 

 

 

10,281

 

 

 

8,801

 

Total noncurrent assets

 

 

539,220

 

 

 

534,786

 

 

 

556,976

 

Total assets

 

$

1,327,747

 

 

$

1,287,677

 

 

$

1,227,081

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

77,188

 

 

$

74,888

 

 

$

65,321

 

Accrued expenses

 

 

37,755

 

 

 

35,232

 

 

 

48,556

 

Operating lease liabilities

 

 

12,741

 

 

 

12,643

 

 

 

12,341

 

Contract liabilities

 

 

14,484

 

 

 

11,144

 

 

 

6,911

 

Current portion of long-term debt and finance lease obligations

 

 

6,043

 

 

 

6,170

 

 

 

5,938

 

Other current liabilities

 

 

9,304

 

 

 

7,685

 

 

 

6,678

 

Total current liabilities

 

 

157,515

 

 

 

147,762

 

 

 

145,745

 

Noncurrent liabilities

 

 

 

 

 

 

 

 

 

Long-term debt and finance lease obligations

 

 

19,041

 

 

 

18,042

 

 

 

34,780

 

Operating lease liabilities

 

 

36,729

 

 

 

39,349

 

 

 

45,634

 

Legal settlement accrual

 

 

51,607

 

 

 

48,803

 

 

 

 

Other long-term liabilities

 

 

4,356

 

 

 

2,816

 

 

 

5,369

 

Total noncurrent liabilities

 

 

111,733

 

 

 

109,010

 

 

 

85,783

 

Total liabilities

 

 

269,248

 

 

 

256,772

 

 

 

231,528

 

Total stockholders’ equity

 

 

1,058,499

 

 

 

1,030,905

 

 

 

995,553

 

Total liabilities and stockholders’ equity

 

$

1,327,747

 

 

$

1,287,677

 

 

$

1,227,081

 

Innovex International, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

Three months ended

 

(in thousands)

 

June 30,

2026

 

March 31,

2026

 

June 30,

2025

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

Net Income (loss)

 

$

25,031

 

 

$

(16,671

)

 

$

15,345

 

Adjustments to reconcile net income to net cash provided by operating activities

 

 

25,211

 

 

 

73,676

 

 

 

29,375

 

Changes in operating assets and liabilities, net of amounts related to acquisitions

 

 

(13,214

)

 

 

(37,165

)

 

 

14,490

 

Net cash provided by operating activities

 

$

37,028

 

 

$

19,840

 

 

$

59,210

 

Cash flows used in investing activities

 

 

 

 

 

 

 

 

 

Payments on acquisitions, net of cash acquired

 

 

(12,041

)

 

 

 

 

 

(63,256

)

Capital expenditures

 

 

(6,641

)

 

 

(5,827

)

 

 

(7,297

)

Proceeds from sale of property and equipment

 

 

5,462

 

 

 

202

 

 

 

7,681

 

Cash acquired in stock based business combination

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

$

(13,220

)

 

$

(5,625

)

 

$

(62,872

)

Cash flows provided by financing activities

 

 

 

 

 

 

 

 

 

Net borrowings (repayments) on line of credit

 

 

 

 

 

 

 

 

13,400

 

Net repayments on term loan

 

 

 

 

 

 

 

 

 

Payments on finance leases

 

 

(1,999

)

 

 

(2,070

)

 

 

(1,869

)

Dividend payment

 

 

 

 

 

 

 

 

 

Other financing

 

 

(388

)

 

 

(14,840

)

 

 

(9,089

)

Net cash provided by (used in) financing activities

 

$

(2,387

)

 

$

(16,910

)

 

$

2,442

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(73

)

 

 

(5

)

 

 

1,885

 

Net change in cash and cash equivalents

 

$

21,348

 

 

$

(2,700

)

 

$

665

 

Non-GAAP Measures

Adjusted EBITDA and Adjusted EBITDA Margin

We define Adjusted EBITDA (a non-GAAP measure) as net income (loss) before interest (income) expense, income tax expense (benefit), net, depreciation and amortization, (gain) loss on sale of assets and other expense, net, further adjusted to exclude certain items which we believe are not reflective of our ongoing performance or which are non-cash in nature. Management uses Adjusted EBITDA to assess the profitability of our business operations and to compare our operating performance to our competitors without regard to the impact of financing methods and capital structure and excluding costs that management believes do not reflect our ongoing operating performance. We track Adjusted EBITDA on an absolute dollar basis and as a percentage of revenue, which we refer to as Adjusted EBITDA Margin.

Free Cash Flow

We also utilize Free Cash Flow (a non-GAAP measure) to evaluate the cash generated by our operations and results of operations. We define Free Cash Flow as net cash provided by operating activities less capital expenditures, as presented in our Consolidated Statements of Cash Flows. Management believes Free Cash Flow is useful because it demonstrates the cash that was available in the period that was in excess of our needs to fund our capital expenditures. We track Free Cash Flow both on an absolute dollar basis and as a percentage of revenue. Free Cash Flow does not represent our residual cash flow available for discretionary expenditures, as we have non-discretionary expenditures, including, but not limited to, any principal payments required under the terms of our credit facility, which are not deducted in calculating Free Cash Flow.

Return on Capital Employed (ROCE)

We utilize Return on Capital Employed (“ROCE”) (a non-GAAP measure) to assess the effectiveness of our capital allocation over time and to compare our capital efficiency to our competitors. We define ROCE as income from operations excluding acquisition and integration costs, litigation related expenses not reflective of our ongoing operating performance, and income tax expense (resulting in Adjusted Income from Operations, after tax) divided by average capital employed. Capital employed is defined as the combined values of debt and stockholders’ equity. We revised our definition of ROCE and Adjusted Income from Operations, after tax to exclude litigation related expenses not reflective of our ongoing operating performance, which for the twelve months ended June 30, 2026 is reflective of the costs related to the Impulse Litigation. In particular, we believe that the exclusion of the aforementioned litigation related expenses eliminated in calculating Adjusted Income from Operations, after tax and ROCE provides useful measures for period-to-period comparisons of our business. We did not revise prior years’ Adjusted Income from Operations, after tax or ROCE because there were no other charges similar in nature to these costs.

Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and ROCE do not represent and should not be considered alternatives to, or more meaningful than, net income and net cash provided by operating activities, or any other measure of financial performance presented in accordance with GAAP as measures of our financial performance. Our computation of Adjusted EBITDA, Free Cash Flow and ROCE may differ from computations of similarly titled measures of other companies. For a reconciliation of these non-GAAP measures to the most directly comparable GAAP measure, see tables below.

Management has provided outlook regarding Adjusted EBITDA, which is a non-GAAP financial measure and excludes certain charges. A reconciliation of this non-GAAP financial measure to the corresponding GAAP financial measure has not been provided because guidance for the various reconciling items is not provided. The Company is unable to provide guidance for these reconciling items because they cannot determine their probable significance, as certain items are outside of the Company’s control and cannot be reasonably predicted since these items could vary significantly from period to period. Accordingly, reconciliations to the corresponding GAAP financial measures are not available without unreasonable effort.

Innovex International, Inc.

Reconciliation of Net Income (Loss) to Adjusted EBITDA

(Unaudited)

 

 

 

Three months ended

 

(in thousands)

 

June 30,

2026

 

March 31,

2026

 

June 30,

2025

Revenue

 

$

244,896

 

 

$

239,031

 

 

$

224,234

 

Net income (loss)

 

 

25,031

 

 

 

(16,671

)

 

 

15,345

 

Interest (income) expense, net

 

 

(653

)

 

 

(388

)

 

 

551

 

Income tax expense

 

 

10,376

 

 

 

(4,923

)

 

 

6,891

 

Depreciation and amortization

 

 

16,213

 

 

 

16,222

 

 

 

14,974

 

EBITDA

 

$

50,967

 

 

$

(5,760

)

 

$

37,761

 

Other non-operating expense (income), net (1)

 

 

(972

)

 

 

150

 

 

 

(92

)

Gain on sale of assets, net

 

 

(9,853

)

 

 

(2,020

)

 

 

(419

)

Impairment of long-lived assets

 

 

 

 

 

 

 

 

503

 

Acquisition and integration costs (2)

 

 

1,613

 

 

 

1,588

 

 

 

5,131

 

Provision for legal settlement (3)

 

 

2,804

 

 

 

48,803

 

 

 

 

Legal defense costs (4)

 

 

 

 

 

2,430

 

 

 

 

Transaction costs (5)

 

 

47

 

 

 

1,128

 

 

 

 

Stock based compensation

 

 

3,391

 

 

 

2,967

 

 

 

3,758

 

Adjusted EBITDA

 

$

47,997

 

 

$

49,286

 

 

$

46,642

 

Net income (loss) % revenue

 

 

10

%

 

 

(7

)%

 

 

7

%

Adjusted EBITDA Margin

 

 

20

%

 

 

21

%

 

 

21

%

(1)

Primarily represents foreign currency exchange (gain) loss, (gain) loss on lease terminations, and other non-operating items.

(2)

Consists of legal, accounting, advisory fees, move, severance and other integration costs associated with acquisitions, primarily related to Dril-Quip, DWS, SCF, Citadel and DIS. These costs are one-time in nature and represent expenses that we do not view as normal operating expenses necessary to operate our business.

(3)

Includes monetary damages awarded by a jury and estimated future awards related to the Impulse Litigation, which is not reflective of our ongoing operating performance.

(4)

Reflects legal defense costs associated with the Impulse Litigation, which is not reflective of our ongoing operating performance. These costs are recorded in Selling, general and administrative expenses in our Condensed Consolidated Statements of Operations and Comprehensive Income.

(5)

Reflects transaction costs associated with the secondary offering.

Innovex International, Inc.

Reconciliation of Income from Operations to ROCE

(Unaudited)

 

 

 

Twelve Months Ended

 

(in thousands)

 

June 30,

2026

 

December 31,

2025

 

June 30,

2025

Income from operations

 

$

100,030

 

 

$

132,625

 

 

$

58,239

 

Plus: Acquisition and integration costs

 

 

11,300

 

 

 

17,518

 

 

 

37,523

 

Plus: Provision for legal settlement (1)

 

 

51,607

 

 

 

 

 

 

 

Plus: Legal defense costs (1)

 

 

2,430

 

 

 

 

 

 

 

Less: Income tax expense

 

 

(37,186

)

 

 

(45,231

)

 

 

(6,536

)

Adjusted income from operations, after tax

 

$

128,181

 

 

$

104,912

 

 

$

89,226

 

Beginning debt

 

 

40,718

 

 

 

35,368

 

 

 

24,752

 

Beginning equity

 

 

995,553

 

 

 

958,156

 

 

 

352,497

 

Ending debt

 

 

25,084

 

 

 

25,631

 

 

 

40,718

 

Ending equity

 

 

1,058,499

 

 

 

1,057,699

 

 

 

995,553

 

Average capital employed

 

$

1,059,927

 

 

$

1,038,427

 

 

$

706,760

 

ROCE

 

 

12

%

 

 

10

%

 

 

13

%

(1)

As defined in our Reconciliation of Net Income (Loss) to Adjusted EBITDA above.

Innovex International, Inc.

Reconciliation of Net Cash from Operations to Free Cash Flow

(Unaudited)

 

 

 

Three months ended

 

(in thousands)

 

June 30,

2026

 

March 31,

2026

 

June 30,

2025

Net cash provided by operating activities

 

$

37,028

 

 

$

19,840

 

 

$

59,210

 

Capital expenditures

 

 

(6,641

)

 

 

(5,827

)

 

 

(7,297

)

Free Cash Flow

 

$

30,387

 

 

$

14,013

 

 

$

51,913

 

Innovex International, Inc.

Geographic Revenue Details

(Unaudited)

 

 

 

Three months ended

 

(in thousands)

 

June 30,

2026

 

March 31,

2026

 

June 30,

2025

North America Onshore (“NAM”)

 

 

 

 

 

 

 

 

 

Products

 

$

86,265

 

 

$

89,522

 

 

$

77,368

 

Services

 

 

16,693

 

 

 

17,020

 

 

 

15,901

 

Rental

 

 

28,477

 

 

 

30,164

 

 

 

26,698

 

Revenue – North America Onshore

 

 

131,435

 

 

 

136,706

 

 

 

119,967

 

International & Offshore

 

 

 

 

 

 

 

 

 

Products

 

 

81,114

 

 

 

73,373

 

 

 

72,081

 

Services

 

 

15,012

 

 

 

14,121

 

 

 

14,881

 

Rental

 

 

17,335

 

 

 

14,831

 

 

 

17,305

 

Revenue – International & Offshore

 

 

113,461

 

 

 

102,325

 

 

 

104,267

 

Total Revenue

 

$

244,896

 

 

$

239,031

 

 

$

224,234

 

 

Media gallery